Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder

Mikael S. Mouradian, Jennifer Rodgers, Jodi Kashmere, Glen Jickling, Jennifer McCombe, Derek J. Emery, Andrew M. Demchuk, Ashfaq Shuaib

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Intravenous rt-PA (IV rt-PA) for acute stroke has raised many concerns, including its inadvertent use in patients presenting with acute stroke-like symptoms as the expression of their somatoform disorder. Diagnosis of the somatoform disorder is often delayed, and thrombolytics in these patients for their stroke-like presentation subjects them to risk for hemorrhage. Methods: The presentation, neurological findings, and the therapeutic decision making was audited in 85 patients who received IV rt-PA for a diagnosis of acute stroke. All the surviving patients were re-examined neurologically at least three months after IV rt-PA. Baseline and follow-up brain CT scans were re-reviewed by a neuroradiologist who was blinded to clinical presentation and outcome. Patients whose clinical presentation, brain CT and neurological outcome did not fit into known or expected anatomical and clinical patterns of stroke underwent psychological assessment using the Minnesota Multiphasic Personality Inventory-2. Results: In two patients three stroke-like presentations of somatoform disorder inadvertently were treated with IV rt-PA. This was primarily caused by abbreviated neurological examination and narrow differential diagnosis. Interpretation: Patients with somatoform disorder may present with symptoms mimicking acute stroke. Under the time constraints of IV rt-PA use, a diagnosis of somatoform disorder can be missed, subjecting such patients to the potential complications of thrombolytics.

Original languageEnglish (US)
Pages (from-to)99-101
Number of pages3
JournalCanadian Journal of Neurological Sciences
Volume31
Issue number1
StatePublished - Feb 2004
Externally publishedYes

Fingerprint

Somatoform Disorders
Stroke
MMPI
Neurologic Examination
Brain
Decision Making
Differential Diagnosis
Hemorrhage
Psychology

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Mouradian, M. S., Rodgers, J., Kashmere, J., Jickling, G., McCombe, J., Emery, D. J., ... Shuaib, A. (2004). Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder. Canadian Journal of Neurological Sciences, 31(1), 99-101.

Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder. / Mouradian, Mikael S.; Rodgers, Jennifer; Kashmere, Jodi; Jickling, Glen; McCombe, Jennifer; Emery, Derek J.; Demchuk, Andrew M.; Shuaib, Ashfaq.

In: Canadian Journal of Neurological Sciences, Vol. 31, No. 1, 02.2004, p. 99-101.

Research output: Contribution to journalArticle

Mouradian, MS, Rodgers, J, Kashmere, J, Jickling, G, McCombe, J, Emery, DJ, Demchuk, AM & Shuaib, A 2004, 'Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder', Canadian Journal of Neurological Sciences, vol. 31, no. 1, pp. 99-101.
Mouradian MS, Rodgers J, Kashmere J, Jickling G, McCombe J, Emery DJ et al. Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder. Canadian Journal of Neurological Sciences. 2004 Feb;31(1):99-101.
Mouradian, Mikael S. ; Rodgers, Jennifer ; Kashmere, Jodi ; Jickling, Glen ; McCombe, Jennifer ; Emery, Derek J. ; Demchuk, Andrew M. ; Shuaib, Ashfaq. / Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder. In: Canadian Journal of Neurological Sciences. 2004 ; Vol. 31, No. 1. pp. 99-101.
@article{1af98365f68c4de49da325827166bc89,
title = "Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder",
abstract = "Background: Intravenous rt-PA (IV rt-PA) for acute stroke has raised many concerns, including its inadvertent use in patients presenting with acute stroke-like symptoms as the expression of their somatoform disorder. Diagnosis of the somatoform disorder is often delayed, and thrombolytics in these patients for their stroke-like presentation subjects them to risk for hemorrhage. Methods: The presentation, neurological findings, and the therapeutic decision making was audited in 85 patients who received IV rt-PA for a diagnosis of acute stroke. All the surviving patients were re-examined neurologically at least three months after IV rt-PA. Baseline and follow-up brain CT scans were re-reviewed by a neuroradiologist who was blinded to clinical presentation and outcome. Patients whose clinical presentation, brain CT and neurological outcome did not fit into known or expected anatomical and clinical patterns of stroke underwent psychological assessment using the Minnesota Multiphasic Personality Inventory-2. Results: In two patients three stroke-like presentations of somatoform disorder inadvertently were treated with IV rt-PA. This was primarily caused by abbreviated neurological examination and narrow differential diagnosis. Interpretation: Patients with somatoform disorder may present with symptoms mimicking acute stroke. Under the time constraints of IV rt-PA use, a diagnosis of somatoform disorder can be missed, subjecting such patients to the potential complications of thrombolytics.",
author = "Mouradian, {Mikael S.} and Jennifer Rodgers and Jodi Kashmere and Glen Jickling and Jennifer McCombe and Emery, {Derek J.} and Demchuk, {Andrew M.} and Ashfaq Shuaib",
year = "2004",
month = "2",
language = "English (US)",
volume = "31",
pages = "99--101",
journal = "Canadian Journal of Neurological Sciences",
issn = "0317-1671",
publisher = "Canadian Journal of Neurological Sciences",
number = "1",

}

TY - JOUR

T1 - Can rt-PA be Administered to the Wrong Patient? Two Patients with Somatoform Disorder

AU - Mouradian, Mikael S.

AU - Rodgers, Jennifer

AU - Kashmere, Jodi

AU - Jickling, Glen

AU - McCombe, Jennifer

AU - Emery, Derek J.

AU - Demchuk, Andrew M.

AU - Shuaib, Ashfaq

PY - 2004/2

Y1 - 2004/2

N2 - Background: Intravenous rt-PA (IV rt-PA) for acute stroke has raised many concerns, including its inadvertent use in patients presenting with acute stroke-like symptoms as the expression of their somatoform disorder. Diagnosis of the somatoform disorder is often delayed, and thrombolytics in these patients for their stroke-like presentation subjects them to risk for hemorrhage. Methods: The presentation, neurological findings, and the therapeutic decision making was audited in 85 patients who received IV rt-PA for a diagnosis of acute stroke. All the surviving patients were re-examined neurologically at least three months after IV rt-PA. Baseline and follow-up brain CT scans were re-reviewed by a neuroradiologist who was blinded to clinical presentation and outcome. Patients whose clinical presentation, brain CT and neurological outcome did not fit into known or expected anatomical and clinical patterns of stroke underwent psychological assessment using the Minnesota Multiphasic Personality Inventory-2. Results: In two patients three stroke-like presentations of somatoform disorder inadvertently were treated with IV rt-PA. This was primarily caused by abbreviated neurological examination and narrow differential diagnosis. Interpretation: Patients with somatoform disorder may present with symptoms mimicking acute stroke. Under the time constraints of IV rt-PA use, a diagnosis of somatoform disorder can be missed, subjecting such patients to the potential complications of thrombolytics.

AB - Background: Intravenous rt-PA (IV rt-PA) for acute stroke has raised many concerns, including its inadvertent use in patients presenting with acute stroke-like symptoms as the expression of their somatoform disorder. Diagnosis of the somatoform disorder is often delayed, and thrombolytics in these patients for their stroke-like presentation subjects them to risk for hemorrhage. Methods: The presentation, neurological findings, and the therapeutic decision making was audited in 85 patients who received IV rt-PA for a diagnosis of acute stroke. All the surviving patients were re-examined neurologically at least three months after IV rt-PA. Baseline and follow-up brain CT scans were re-reviewed by a neuroradiologist who was blinded to clinical presentation and outcome. Patients whose clinical presentation, brain CT and neurological outcome did not fit into known or expected anatomical and clinical patterns of stroke underwent psychological assessment using the Minnesota Multiphasic Personality Inventory-2. Results: In two patients three stroke-like presentations of somatoform disorder inadvertently were treated with IV rt-PA. This was primarily caused by abbreviated neurological examination and narrow differential diagnosis. Interpretation: Patients with somatoform disorder may present with symptoms mimicking acute stroke. Under the time constraints of IV rt-PA use, a diagnosis of somatoform disorder can be missed, subjecting such patients to the potential complications of thrombolytics.

UR - http://www.scopus.com/inward/record.url?scp=1542374133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542374133&partnerID=8YFLogxK

M3 - Article

C2 - 15038478

AN - SCOPUS:1542374133

VL - 31

SP - 99

EP - 101

JO - Canadian Journal of Neurological Sciences

JF - Canadian Journal of Neurological Sciences

SN - 0317-1671

IS - 1

ER -